Carolina Liquid Chemistries (CLC) will distribute its Flowflex COVID-19 Antigen Home Test kit via a new partnership the company made with authorized distributor Alltests Clinical Solutions.
Manufactured by ACON Laboratories, Inc., Flowflex is a rapid antigen self-test that does not require a prescription.
On Oct. 4, 2021, ACON Laboratories was granted an emergency use authorization (EUA) by the U.S. Food and Drug Administration that will significantly increase the availability of a rapid, at-home test to public authorities and private companies. In light of the most recent mandates established by the U.S. Government, a massive number of COVID-19 tests will be required to fulfill weekly testing of unvaccinated public and private sector employees.
CLC has partnered with an international alliance of professionals in the medical, pharmaceutical, marketing, and entrepreneurial fields who seek to provide innovative, effective, and pragmatic solutions in the global battle against the COVID-19 pandemic.
Learn more about the Flowflex COVID-19 Antigen Home Test through CLC’s corporate website at www.carolinachemistries.com.
Featured image: Flowflex is a rapid antigen self-test that does not require a prescription. Photo: Carolina Liquid Chemistries
